Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The International Cell Surgical Society (ICSS) is a non-profit organization dedicated to the advancement of regenerative medicine through the standardization of autologous cell-based therapies. The society provides clinical protocols, physician training, and maintains a comprehensive clinical registry to track patient outcomes and safety data for point-of-care stem cell procedures. ICSS focuses on ensuring that surgical cell procedures are performed safely and ethically, primarily supporting practitioners in the fields of orthopedics, urology, and aesthetic medicine. By providing an Institutional Review Board (IRB) approved framework, the society enables clinicians to contribute to large-scale data collection on the efficacy of stromal vascular fraction (SVF) and other cell-based treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Cell Surgical Society.